Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Other Comprehensive Income (Loss)

v3.22.1
Consolidated Statements of Operations and Other Comprehensive Income (Loss) - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenues, net $ 79,042,000 $ 14,514,000
Cost of revenues 37,054,000 9,908,000
Gross profit 41,988,000 4,606,000
Operating expenses:    
Diagnostic expenses 9,174,000 448,000
General and administration 22,493,000 7,498,000
Research and development 520,000 633,000
Total operating expenses 32,187,000 8,579,000
Gain on sale of real estate 1,892,000
Income (loss) from operations 9,801,000 (2,081,000)
Interest income, net 642,000 62,000
Interest expense (1,148,000) (295,000)
Change in fair value of investment securities (240,000)
Impairment of secured promissory note receivable (3,750,000)
Income (loss) from continuing operations before income taxes 5,305,000 (2,314,000)
Income tax benefit (expense) 968,000 (12,000)
Income (loss) from continuing operations after income taxes 6,273,000 (2,326,000)
Discontinued Operations:    
Income from discontinued operations 201,000
Net income (loss) 6,273,000 (2,125,000)
Other comprehensive loss:    
Unrealized loss on marketable debt securities (164,000) (9,000)
Total comprehensive income (loss) $ 6,109,000 $ (2,134,000)
Basic and earnings (loss) per share:    
Income (loss) from continuing operations $ 0.41 $ (0.20)
Income from discontinued operations 0.02
Net income (loss) per share 0.41 (0.18)
Diluted earnings (loss) per share:    
Income (loss) from continuing operations 0.40 (0.20)
Income from discontinued operations 0.02
Net income (loss) per share $ 0.40 $ (0.18)
Weighted average common shares outstanding:    
Basic 15,172 11,595
Diluted 18,393 11,595